CPHI PHARMA AWARD 2022

PROCOS SPA Announces the candidacy of Mr. Zodio as CEO of Year, CPHI PHARMA AWARD 2022

PROCOS has proved to be a strong, dynamic Company with enormous potential over the years. The secret of our success is the People and among them we have our CEO, Mr. Enrico Zodio who is among the finalists of the CPHI PHARMA AWARDS 2022 as CEO OF THE YEAR.

Born in Padua Italy, in 1965, the life of our CEO has always been directed towards the world of Pharma, but what makes him unique is certainly his ability to adapt, his proud and combative spirit and, above all, his foresight. Mr. Zodio studied at Padova University, he earned a degree in Chemistry and after 8 years in other Chemical Pharma Companies, he finally joined Procos in 1999. He spent 10 years working in global sales before becoming the CEO in 2010.

Since becoming part of the Japanese Group CBC CO., LTD, in 2006, the concept of Brand Awareness as well as the strong expansion towards the international market has been achieved thanks to the commitment and perseverance put in place by Mr. Zodio who, is committed to maintaining constant time investments, the growth of personnel and technology, but above all the growth of a strong environmental and health policy for workers.

“Today, PROCOS is achieving sales over €200 million in turnover and a continuous increase in production capacity that makes our organization a flagship of the Italian scene, as attested by the Felix Award, a prize given to the top Italian companies with a sustainable growth plan.” said Mr. Enrico Zodio, CEO of PROCOS S.P.A.

The people of PROCOS, its local community, the global CBC network and worldwide customers thank Mr. Zodio for his profound efforts toward growth, sustainability and the well-being of humans.  His vision and leadership skills are the glue that have brought together and will lead PROCOS towards a splendid future.